Our previous results confirmed that suppression of Akt and the NF-κB/Bcl-2 pathway by anticancer agents inhibited the migration and growth as well as induced the apoptosis in human breast and lung cancer cells [19-20; 23; 30]. This evidence concerns the gene AKT1 and lung carcinoma.